Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 8, Issue 6, Pages e2844
Publisher
Springer Nature
Online
2017-06-01
DOI
10.1038/cddis.2017.226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma
- (2016) Susana Galli et al. AMERICAN JOURNAL OF PATHOLOGY
- Cancer stem cell drugs target K-ras signaling in a stemness context
- (2016) A K Najumudeen et al. ONCOGENE
- CD133, Selectively Targeting the Root of Cancer
- (2016) Jörg Schmohl et al. Toxins
- New horizons in tumor microenvironment biology: challenges and opportunities
- (2015) Fei Chen et al. BMC Medicine
- The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
- (2015) Vicki Plaks et al. Cell Stem Cell
- Harnessing the apoptotic programs in cancer stem-like cells
- (2015) Y.-H. Wang et al. EMBO REPORTS
- Sorafenib: 10 years after the first pivotal trial
- (2015) Gennaro Gadaleta-Caldarola et al. Future Oncology
- Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?
- (2015) Alexandru Dan Grigore et al. Frontiers in Oncology
- Systemic use of tumor necrosis factor alpha as an anticancer agent
- (2015) Nicholas J. Roberts et al. Oncotarget
- CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist
- (2014) S. Sarvi et al. CANCER RESEARCH
- Targeting proapoptotic protein BAD inhibits survival and self-renewal of cancer stem cells
- (2014) K S R Sastry et al. CELL DEATH AND DIFFERENTIATION
- Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer
- (2014) A Zeuner et al. CELL DEATH AND DIFFERENTIATION
- Chemical approaches to targeting drug resistance in cancer stem cells
- (2014) Panagiota A. Sotiropoulou et al. DRUG DISCOVERY TODAY
- Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
- (2013) Amy P.N. Skubitz et al. GYNECOLOGIC ONCOLOGY
- Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/β-catenin/CBP pathway
- (2013) Kaijie He et al. INTERNATIONAL JOURNAL OF CANCER
- Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
- (2013) Akintunde Akinleye et al. Journal of Hematology & Oncology
- VPAC1 Receptors for Imaging Breast Cancer: A Feasibility Study
- (2013) M. L. Thakur et al. JOURNAL OF NUCLEAR MEDICINE
- Mechanisms and insights into drug resistance in cancer
- (2013) Hiba Zahreddine et al. Frontiers in Pharmacology
- CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer
- (2012) T J Liu et al. ONCOGENE
- VIP-targeted cytotoxic nanomedicine for breast cancer
- (2012) Aparna Dagar et al. Drug Delivery and Translational Research
- Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
- (2011) C. L. Chaffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1
- (2010) Ana B. Fernández-Martínez et al. CANCER LETTERS
- New promising drug targets in cancer- and metastasis-initiating cells
- (2010) Murielle Mimeault et al. DRUG DISCOVERY TODAY
- The therapeutic promise of the cancer stem cell concept
- (2010) Natasha Y. Frank et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- Protein Kinase A Activation Confers Resistance to Trastuzumab in Human Breast Cancer Cell Lines
- (2009) L. Gu et al. CLINICAL CANCER RESEARCH
- Targeting CD133 antigen in cancer
- (2009) Gabriella Ferrandina et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Vasoactive intestinal peptide acts via multiple signal pathways to regulate hippocampal NMDA receptors and synaptic transmission
- (2009) Kai Yang et al. HIPPOCAMPUS
- Cancer Stem Cells: A Step Toward the Cure
- (2008) Bruce M. Boman et al. JOURNAL OF CLINICAL ONCOLOGY
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- Vasoactive intestinal peptide (VIP) induces transactivation of EGFR and HER2 in human breast cancer cells
- (2008) Ana Valdehita et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation